NDC 66689-031-01 - Metoclopramide Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-031
- Requested NDC
- 66689-031-01
- Package NDCs from labels
- 66689-031-01, 66689-031-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide Hydrochloride - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-031-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-276c-111a-e063-dadaa90a10e2 | METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-031-01 | ML - Milliliter | 66689-031 | 21c6cdb2-83f7-412d-beb1-8dd49b4ba7f3 | 1 | 2013-02-13 |
| 66689-031-50 | ML - Milliliter | 66689-031 | 7ec00a6a-fe58-4173-80a2-fd83172446f1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Metoclopramide Hydrochloride | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| Metoclopramide | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 374a2ca3-ee04-09a7-e063-6394a90ab760 | 2026-05-05 | Warnings | PDC6A3C0OX |
| Metoclopramide | METOCLOPRAMIDE | ScieGen Pharmaceuticals, Inc. | b16ad17c-eeea-407e-91e4-36506e9aa698 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 50a3cf38-66dc-4fa5-8a45-adf959c987ab | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| REFRESH TEARS PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 9e1cba7b-84ed-47f3-b19a-121992834350 | 2026-04-24 | Warnings | PDC6A3C0OX |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | cccf04bd-7463-40b8-a41f-cb1093c358d7 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Pure Eyes Sterile Eyes | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | SAMSON PHARMACEUTICAL | c0234e82-211f-4731-ac48-12db13b16e8a | 2026-04-21 | Warnings | PDC6A3C0OX |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | XF417D3PSL |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | 5645a752-8868-4b51-8b59-48bb4276d763 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| METOCLOPRAMIDE | METOCLOPRAMIDE | HF Acquisition Co LLC, DBA HealthFirst | 4046830f-4b87-5e6e-e063-6394a90aeeb8 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
| blink boost | GLYCERIN | Bausch & Lomb Incorporated | e765c224-1718-488f-99b2-976eb60c1d63 | 2026-04-13 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream with Lidocaine | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 4f1ef866-c4af-989b-e063-6294a90a148e | 2026-04-10 | Warnings | PDC6A3C0OX |
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| Metoclopramide | METOCLOPRAMIDE | Teva Pharmaceuticals USA, Inc. | e15905e0-e0f6-4c8b-ac19-59724d6c4bf0 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Redness Relief | GLYCERIN, NAPHAZOLINE HCL | Pharmadel LLC | 4c113bb9-814f-d92d-e063-6294a90a8302 | 2026-03-30 | Warnings | PDC6A3C0OX |
| Moisture Oyster | GLYCERIN | Moisture Oyster Inc | 4e45317a-437f-4d88-e063-6294a90a98d0 | 2026-03-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.